During this segment, Yehuda Handelsman, MD, FACP, FACE, FNLA, and Kenneth L. Schaecher, MD, FACP, CPC, discuss how organizations are developing programs that aim to help control diabetes and the obesity epidemic.
Dr Handelsman believes that as clinicians continue to individualize the management of cardiometabolic events and treat patients with single-agents that treat multiple conditions, our country is at the forefront of controlling future events.
For this reason, Dr Schaecher explains the importance of healthcare programs such as the National Diabetes Prevention Program and other nationwide initiatives that provide guidance to clinicians on a local level and force patient involvement. Dr Schaecher expresses that when controlling cardiometabolic events, patient involvement is vital.
Because patient involvement includes localized initiatives, Dr Handelsman and Dr Schaecher conclude their discussion by explaining how community resources are taking steps to ensure patient involvement.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Impact of Hospital-Physician Integration on Medicare Patient Mix
April 11th 2025This study found no evidence that hospital employment of physicians resulted in physicians treating sicker patients, undercutting claims that hospital-employed physicians serve a higher-acuity patient mix.
Read More